カテゴリ： Allied Market Research, 世界, 医療/バイオ

医療用外骨格のグローバル市場（2021～2031）：パワード型外骨格、パッシブ型外骨格

■ 英語タイトル：Medical Exoskeleton Market By Type (Powered exoskeleton, Passive exoskeleton), By Mobility (Stationary, Mobile), By Component (Hardware, Software), By Application (Spinal Cord Injury, Stroke, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23MC082）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23MC082
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：264
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[医療用外骨格のグローバル市場（2021～2031）：パワード型外骨格、パッシブ型外骨格]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の調査資料では、2021年には232.5百万ドルであった世界の医療用外骨格市場規模が2031年には3,044.7百万ドルへ及び、2022年から2031年の間にCAGR 29.4％増加すると推測されています。本調査資料では、医療用外骨格の世界市場を広く調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、種類別（パワード型外骨格、パッシブ型外骨格）分析、モビリティ別（定置型、移動型）分析、コンポーネント別（ハードウェア、ソフトウェア）分析、用途別（脊髄損傷、脳卒中、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ）分析、競争状況、企業情報などを整理しました。並びに、本資料に記載されている企業として、CYBERDYNE INC.、Ekso Bionics、B-Temia、Rewalk Robotics、Ottobock SE & Co. KGaA (suit X)、DIH Medical、Ergosante、ExoAtlet、Human Motion Technologies LLC、Wearable Robotics srlなどが含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の医療用外骨格市場規模：種類別
- パワード型外骨格の市場規模
- パッシブ型外骨格の市場規模
・世界の医療用外骨格市場規模：モビリティ別
- 定置型医療用外骨格の市場規模
- 移動型医療用外骨格の市場規模
・世界の医療用外骨格市場規模：コンポーネント別
- ハードウェアの市場規模
- ソフトウェアの市場規模
・世界の医療用外骨格市場規模：用途別
- 脊髄損傷における市場規模
- 脳卒中における市場規模
- その他用途における市場規模
・世界の医療用外骨格市場規模：地域別
- 北米の医療用外骨格市場規模
- ヨーロッパの医療用外骨格市場規模
- アジア太平洋の医療用外骨格市場規模
- 中南米/中東・アフリカの医療用外骨格市場規模
・競争状況
・企業情報

医療用外骨格の世界市場規模は、2021年に2億3,250万ドル、2031年には30億4,470万ドルに達すると予測され、2022年から2031年までのCAGRは29.4%となる見込みです。
医療用外骨格は、患者が怪我から回復するのを助けたり、歩行リハビリテーションやロコモーション補助のための装具のような生物学的能力を強化するために、身体に装着する外部フレームワークとして開発されたウェアラブル電気機械装置です。そのため、このフレームは手足に余分な動き、強さ、持久力を提供します。医療用外骨格は、脊髄損傷(SCI)、神経障害、脳卒中などの外傷、脳性麻痺など、様々な病状に苦しむ障害者、負傷者、弱者を支援するために使用されます。これらの医療用外骨格は、通常、病院やリハビリセンターなどの監視された環境で、医療専門家の監督下で使用されます。

医療用外骨格市場の成長は、さまざまな医療用外骨格デバイスの開発における技術進歩、脊髄損傷や多発性硬化症、パーキンソン病などの神経疾患の有病率の上昇によってもたらされます。また、障害に苦しむ人々の増加は、医療用外骨格の需要を促進し、市場の成長を促進すると予測されています。例えば、世界保健機関(WHO)によると、2022年12月に、推定13億人、つまり世界人口の16%が重大な障害を経験していると報告されました。この数は、神経疾患の有病率の増加や高齢者人口の増加によって増加しています。さらに、脊髄損傷、多発性硬化症、パーキンソン病などの神経疾患を患う人々の増加が、医療用外骨格デバイスの需要を増加させ、市場の成長を後押ししています。例えば、National Spinal Cord Injury Model Systems Database (NSCMSD)によると、2022年6月には、約51000人が脊髄損傷に苦しんでいると報告されています。

さらに、多発性硬化症、パーキンソン病、脳卒中などの神経疾患の有病率の上昇は、医療用外骨格デバイスの需要を促進し、市場の成長を促進すると予想されています。例えば、全米多発性硬化症協会によると、2020年9月には世界で約280万人が多発性硬化症（MS）に苦しんでいると報告されています。また、同出典によると、そのうちの100万人近くが2020年に米国で生活していると報告されています。

さらに、医療費の増加、可処分所得の増加、発展途上国における中流階級の人口拡大は、医療用外骨格市場の成長を促進する有利な成長機会を生み出すと期待されています。また、高齢者人口は神経疾患や整形外科疾患にかかりやすい。したがって、高齢者人口の増加は、医療用外骨格デバイスの需要を煽り、市場成長を促進すると予想されます。例えば、Population Reference Bureauによると、2019年、アジアやヨーロッパなどの地域は、65歳以上の世界最高齢人口の本拠地となっています。トップは日本の28％、次いでイタリアの23％。フィンランド、ポルトガル、ギリシャが22％弱でトップ5を占めています。

さらに、医療インフラを整備するための政府支出の増加が市場の成長を後押ししています。例えば、国家統計局によると、英国の総医療費は国内総生産（GDP）の12.0％を占め、2019年には9.9％でした。さらに、医療支出の30%は、医療インフラ、特に病院などの公的医療機関で使用される医療機器やアプリケーションのアップグレードに使用されると推定されています。したがって、世界中の医療費の増加は、障害者人口における医療用外骨格アプリケーションの需要を促進し、それによって市場の成長を後押しすることが期待されています。
一方、医療用外骨格デバイスの高コストとデバイスの安全性への懸念は、医療用外骨格市場の成長を抑制すると予想されるいくつかの要因です。

医療用外骨格市場は、種類、コンポーネント、モビリティ、アプリケーションに区分されます。
種類別では、市場は動力式外骨格と受動式外骨格に分けられます。
コンポーネント別では、市場はハードウェアとソフトウェアに分けられます。
モビリティ別では、市場は定置型と移動型に二分されます。
用途別では、市場は脊髄損傷、脳卒中、その他に分けられます。その他には、多発性硬化症、変形性関節症、パーキンソン病、後天性脳損傷などが含まれます。
地域別では、北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。

世界の医療用外骨格市場で事業を展開している主要企業には、CYBERDYNE INC.、Ekso Bionics、Ergosanté、B-Temia、ExoAtlet、ReWalk Robotics、Ottobock SE & Co. KGaA（suit X）、DIH medical Hocoma.、Human Motion Technologies LLC.、Wearable Robotics srl.などがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの医療用外骨格市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、医療用外骨格市場の有力な市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
・医療用外骨格市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界の医療用外骨格市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
種類別
動力式外骨格
パッシブ外骨格

移動性別
定置型
移動型

コンポーネント別
ハードウェア
ソフトウェア

用途別
脊髄損傷
脳卒中
その他

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

主な市場プレイヤー
CYBERDYNE INC.
Ekso Bionics
B-Temia
Rewalk Robotics
Ottobock SE & Co. KGaA (suit X)
DIH Medical
Ergosante
ExoAtlet
Human Motion Technologies LLC
Wearable Robotics srl

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. High threat of substitutes
3.3.4. High threat of new entrants
3.3.5. High intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of neurological disorders.
3.4.1.2. Increase in the number of spinal cord injuries and brain injuries.
3.4.1.3. Rise in the number of geriatric populations.

3.4.2. Restraints
3.4.2.1. Regulatory challenges for securing approvals for medical applications of exoskeletons.

3.4.3. Opportunities
3.4.3.1. Increase in the number of product approvals by market players.
3.4.3.2. Rise in the number of adoptions of key strategies by market players

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: MEDICAL EXOSKELETON MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Powered exoskeleton
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Passive exoskeleton
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: MEDICAL EXOSKELETON MARKET, BY MOBILITY
5.1. Overview
5.1.1. Market size and forecast
5.2. Stationary
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Mobile
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: MEDICAL EXOSKELETON MARKET, BY COMPONENT
6.1. Overview
6.1.1. Market size and forecast
6.2. Hardware
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Software
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
CHAPTER 7: MEDICAL EXOSKELETON MARKET, BY APPLICATION
7.1. Overview
7.1.1. Market size and forecast
7.2. Spinal Cord Injury
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Stroke
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: MEDICAL EXOSKELETON MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. Market size and forecast, by Type
8.2.3. Market size and forecast, by Mobility
8.2.4. Market size and forecast, by Component
8.2.5. Market size and forecast, by Application
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Key market trends, growth factors and opportunities
8.2.6.1.2. Market size and forecast, by Type
8.2.6.1.3. Market size and forecast, by Mobility
8.2.6.1.4. Market size and forecast, by Component
8.2.6.1.5. Market size and forecast, by Application
8.2.6.2. Canada
8.2.6.2.1. Key market trends, growth factors and opportunities
8.2.6.2.2. Market size and forecast, by Type
8.2.6.2.3. Market size and forecast, by Mobility
8.2.6.2.4. Market size and forecast, by Component
8.2.6.2.5. Market size and forecast, by Application
8.2.6.3. Mexico
8.2.6.3.1. Key market trends, growth factors and opportunities
8.2.6.3.2. Market size and forecast, by Type
8.2.6.3.3. Market size and forecast, by Mobility
8.2.6.3.4. Market size and forecast, by Component
8.2.6.3.5. Market size and forecast, by Application
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Market size and forecast, by Type
8.3.3. Market size and forecast, by Mobility
8.3.4. Market size and forecast, by Component
8.3.5. Market size and forecast, by Application
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Key market trends, growth factors and opportunities
8.3.6.1.2. Market size and forecast, by Type
8.3.6.1.3. Market size and forecast, by Mobility
8.3.6.1.4. Market size and forecast, by Component
8.3.6.1.5. Market size and forecast, by Application
8.3.6.2. France
8.3.6.2.1. Key market trends, growth factors and opportunities
8.3.6.2.2. Market size and forecast, by Type
8.3.6.2.3. Market size and forecast, by Mobility
8.3.6.2.4. Market size and forecast, by Component
8.3.6.2.5. Market size and forecast, by Application
8.3.6.3. UK
8.3.6.3.1. Key market trends, growth factors and opportunities
8.3.6.3.2. Market size and forecast, by Type
8.3.6.3.3. Market size and forecast, by Mobility
8.3.6.3.4. Market size and forecast, by Component
8.3.6.3.5. Market size and forecast, by Application
8.3.6.4. Italy
8.3.6.4.1. Key market trends, growth factors and opportunities
8.3.6.4.2. Market size and forecast, by Type
8.3.6.4.3. Market size and forecast, by Mobility
8.3.6.4.4. Market size and forecast, by Component
8.3.6.4.5. Market size and forecast, by Application
8.3.6.5. Spain
8.3.6.5.1. Key market trends, growth factors and opportunities
8.3.6.5.2. Market size and forecast, by Type
8.3.6.5.3. Market size and forecast, by Mobility
8.3.6.5.4. Market size and forecast, by Component
8.3.6.5.5. Market size and forecast, by Application
8.3.6.6. Rest of Europe
8.3.6.6.1. Key market trends, growth factors and opportunities
8.3.6.6.2. Market size and forecast, by Type
8.3.6.6.3. Market size and forecast, by Mobility
8.3.6.6.4. Market size and forecast, by Component
8.3.6.6.5. Market size and forecast, by Application
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Market size and forecast, by Type
8.4.3. Market size and forecast, by Mobility
8.4.4. Market size and forecast, by Component
8.4.5. Market size and forecast, by Application
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Key market trends, growth factors and opportunities
8.4.6.1.2. Market size and forecast, by Type
8.4.6.1.3. Market size and forecast, by Mobility
8.4.6.1.4. Market size and forecast, by Component
8.4.6.1.5. Market size and forecast, by Application
8.4.6.2. China
8.4.6.2.1. Key market trends, growth factors and opportunities
8.4.6.2.2. Market size and forecast, by Type
8.4.6.2.3. Market size and forecast, by Mobility
8.4.6.2.4. Market size and forecast, by Component
8.4.6.2.5. Market size and forecast, by Application
8.4.6.3. India
8.4.6.3.1. Key market trends, growth factors and opportunities
8.4.6.3.2. Market size and forecast, by Type
8.4.6.3.3. Market size and forecast, by Mobility
8.4.6.3.4. Market size and forecast, by Component
8.4.6.3.5. Market size and forecast, by Application
8.4.6.4. Australia
8.4.6.4.1. Key market trends, growth factors and opportunities
8.4.6.4.2. Market size and forecast, by Type
8.4.6.4.3. Market size and forecast, by Mobility
8.4.6.4.4. Market size and forecast, by Component
8.4.6.4.5. Market size and forecast, by Application
8.4.6.5. South Korea
8.4.6.5.1. Key market trends, growth factors and opportunities
8.4.6.5.2. Market size and forecast, by Type
8.4.6.5.3. Market size and forecast, by Mobility
8.4.6.5.4. Market size and forecast, by Component
8.4.6.5.5. Market size and forecast, by Application
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Key market trends, growth factors and opportunities
8.4.6.6.2. Market size and forecast, by Type
8.4.6.6.3. Market size and forecast, by Mobility
8.4.6.6.4. Market size and forecast, by Component
8.4.6.6.5. Market size and forecast, by Application
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. Market size and forecast, by Type
8.5.3. Market size and forecast, by Mobility
8.5.4. Market size and forecast, by Component
8.5.5. Market size and forecast, by Application
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Key market trends, growth factors and opportunities
8.5.6.1.2. Market size and forecast, by Type
8.5.6.1.3. Market size and forecast, by Mobility
8.5.6.1.4. Market size and forecast, by Component
8.5.6.1.5. Market size and forecast, by Application
8.5.6.2. Saudi Arabia
8.5.6.2.1. Key market trends, growth factors and opportunities
8.5.6.2.2. Market size and forecast, by Type
8.5.6.2.3. Market size and forecast, by Mobility
8.5.6.2.4. Market size and forecast, by Component
8.5.6.2.5. Market size and forecast, by Application
8.5.6.3. South Africa
8.5.6.3.1. Key market trends, growth factors and opportunities
8.5.6.3.2. Market size and forecast, by Type
8.5.6.3.3. Market size and forecast, by Mobility
8.5.6.3.4. Market size and forecast, by Component
8.5.6.3.5. Market size and forecast, by Application
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Key market trends, growth factors and opportunities
8.5.6.4.2. Market size and forecast, by Type
8.5.6.4.3. Market size and forecast, by Mobility
8.5.6.4.4. Market size and forecast, by Component
8.5.6.4.5. Market size and forecast, by Application
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top player positioning, 2021
CHAPTER 10: COMPANY PROFILES
10.1. CYBERDYNE INC.
10.1.1. Company overview
10.1.2. Key Executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Ekso Bionics
10.2.1. Company overview
10.2.2. Key Executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Ergosante
10.3.1. Company overview
10.3.2. Key Executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.4. B-Temia
10.4.1. Company overview
10.4.2. Key Executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. ExoAtlet
10.5.1. Company overview
10.5.2. Key Executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.6. Rewalk Robotics
10.6.1. Company overview
10.6.2. Key Executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.6.7. Key strategic moves and developments
10.7. Ottobock SE & Co. KGaA (suit X)
10.7.1. Company overview
10.7.2. Key Executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.8. Human Motion Technologies LLC
10.8.1. Company overview
10.8.2. Key Executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. Wearable Robotics srl
10.9.1. Company overview
10.9.2. Key Executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. DIH Medical
10.10.1. Company overview
10.10.2. Key Executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio

LIST OF TABLES
TABLE 01. GLOBAL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 02. MEDICAL EXOSKELETON MARKET FOR POWERED EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 03. MEDICAL EXOSKELETON MARKET FOR PASSIVE EXOSKELETON, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 04. GLOBAL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 05. MEDICAL EXOSKELETON MARKET FOR STATIONARY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 06. MEDICAL EXOSKELETON MARKET FOR MOBILE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 07. GLOBAL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 08. MEDICAL EXOSKELETON MARKET FOR HARDWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 09. MEDICAL EXOSKELETON MARKET FOR SOFTWARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. GLOBAL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. MEDICAL EXOSKELETON MARKET FOR SPINAL CORD INJURY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. MEDICAL EXOSKELETON MARKET FOR STROKE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 13. MEDICAL EXOSKELETON MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. MEDICAL EXOSKELETON MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 16. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 17. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 18. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 20. U.S. MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 21. U.S. MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 22. U.S. MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 23. U.S. MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 24. CANADA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 25. CANADA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 26. CANADA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 27. CANADA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 28. MEXICO MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 29. MEXICO MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 30. MEXICO MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 32. EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 36. EUROPE MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 37. GERMANY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 39. GERMANY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 40. GERMANY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 42. FRANCE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 43. FRANCE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 44. FRANCE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 45. UK MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. UK MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 47. UK MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 48. UK MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ITALY MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 50. ITALY MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 51. ITALY MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 52. ITALY MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 53. SPAIN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 54. SPAIN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 55. SPAIN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 56. SPAIN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 57. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 59. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 60. REST OF EUROPE MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 61. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 63. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 64. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 65. ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 66. JAPAN MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 67. JAPAN MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 68. JAPAN MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 69. JAPAN MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 70. CHINA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. CHINA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 72. CHINA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 73. CHINA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 74. INDIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. INDIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 76. INDIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 77. INDIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 78. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 79. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 80. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 81. AUSTRALIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 82. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SOUTH KOREA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 86. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 88. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF ASIA-PACIFIC MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 90. LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 91. LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 92. LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 93. LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 94. LAMEA MEDICAL EXOSKELETON MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 95. BRAZIL MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 96. BRAZIL MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 97. BRAZIL MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 98. BRAZIL MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 99. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 100. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 101. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 102. SAUDI ARABIA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 103. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 104. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 105. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 106. SOUTH AFRICA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 107. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 108. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021-2031 (REVENUE, $MILLION)
TABLE 109. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)
TABLE 110. REST OF LAMEA MEDICAL EXOSKELETON MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
TABLE 111. CYBERDYNE INC.: KEY EXECUTIVES
TABLE 112. CYBERDYNE INC.: COMPANY SNAPSHOT
TABLE 113. CYBERDYNE INC.: PRODUCT SEGMENTS
TABLE 114. CYBERDYNE INC.: PRODUCT PORTFOLIO
TABLE 115. CYBERDYNE INC.: KEY STRATERGIES
TABLE 116. EKSO BIONICS: KEY EXECUTIVES
TABLE 117. EKSO BIONICS: COMPANY SNAPSHOT
TABLE 118. EKSO BIONICS: PRODUCT SEGMENTS
TABLE 119. EKSO BIONICS: PRODUCT PORTFOLIO
TABLE 120. EKSO BIONICS: KEY STRATERGIES
TABLE 121. ERGOSANTE: KEY EXECUTIVES
TABLE 122. ERGOSANTE: COMPANY SNAPSHOT
TABLE 123. ERGOSANTE: PRODUCT SEGMENTS
TABLE 124. ERGOSANTE: PRODUCT PORTFOLIO
TABLE 125. B-TEMIA: KEY EXECUTIVES
TABLE 126. B-TEMIA: COMPANY SNAPSHOT
TABLE 127. B-TEMIA: PRODUCT SEGMENTS
TABLE 128. B-TEMIA: PRODUCT PORTFOLIO
TABLE 129. B-TEMIA: KEY STRATERGIES
TABLE 130. EXOATLET: KEY EXECUTIVES
TABLE 131. EXOATLET: COMPANY SNAPSHOT
TABLE 132. EXOATLET: PRODUCT SEGMENTS
TABLE 133. EXOATLET: PRODUCT PORTFOLIO
TABLE 134. REWALK ROBOTICS: KEY EXECUTIVES
TABLE 135. REWALK ROBOTICS: COMPANY SNAPSHOT
TABLE 136. REWALK ROBOTICS: PRODUCT SEGMENTS
TABLE 137. REWALK ROBOTICS: PRODUCT PORTFOLIO
TABLE 138. REWALK ROBOTICS: KEY STRATERGIES
TABLE 139. OTTOBOCK SE & CO. KGAA (SUIT X): KEY EXECUTIVES
TABLE 140. OTTOBOCK SE & CO. KGAA (SUIT X): COMPANY SNAPSHOT
TABLE 141. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT SEGMENTS
TABLE 142. OTTOBOCK SE & CO. KGAA (SUIT X): PRODUCT PORTFOLIO
TABLE 143. HUMAN MOTION TECHNOLOGIES LLC: KEY EXECUTIVES
TABLE 144. HUMAN MOTION TECHNOLOGIES LLC: COMPANY SNAPSHOT
TABLE 145. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT SEGMENTS
TABLE 146. HUMAN MOTION TECHNOLOGIES LLC: PRODUCT PORTFOLIO
TABLE 147. WEARABLE ROBOTICS SRL: KEY EXECUTIVES
TABLE 148. WEARABLE ROBOTICS SRL: COMPANY SNAPSHOT
TABLE 149. WEARABLE ROBOTICS SRL: PRODUCT SEGMENTS
TABLE 150. WEARABLE ROBOTICS SRL: PRODUCT PORTFOLIO
TABLE 151. DIH MEDICAL: KEY EXECUTIVES
TABLE 152. DIH MEDICAL: COMPANY SNAPSHOT
TABLE 153. DIH MEDICAL: PRODUCT SEGMENTS
TABLE 154. DIH MEDICAL: PRODUCT PORTFOLIO

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 医療用外骨格のグローバル市場：ハードウェア、ソフトウェア
  • 粉塵制御装置のグローバル市場（2021〜2031）：湿式、乾式
  • 雪崩レーダーのグローバル市場（2021-2031）：長距離、短距離
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23MC082 )"医療用外骨格のグローバル市場（2021～2031）：パワード型外骨格、パッシブ型外骨格" (英文：Medical Exoskeleton Market By Type (Powered exoskeleton, Passive exoskeleton), By Mobility (Stationary, Mobile), By Component (Hardware, Software), By Application (Spinal Cord Injury, Stroke, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。